Market Recap — November 2, 2026
Recap of insider activity, SEC filings, and market-moving news for November 2, 2026.
Last generated Nov 3, 2026, 6:58 PM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Children's Place Preparing Bankruptcy Filing as Early as Next Week
Karyopharm Files Chapter 11, Strikes Ayrmid Merger With $55M DIP; Equity Wiped Out
Marvell to Acquire Lumentum in $115B All-Stock Deal at 4.500 Exchange Ratio
Marvell Files $115B Lumentum Merger Agreement: 4.5:1 All-Stock, $5.8B Break Fee
Marvell to Acquire Lumentum in $115B All-Stock Deal, 4.5:1 Exchange Ratio
LS Power Offers $2.00/Share Cash to Buy Out EVgo Minority Holders
Marvell and Lumentum Agree to Combine in AI Connectivity Deal
Perion Signs $11.70/Share All-Cash Merger With Affle, ~$420M Equity Value
$855M LG Chem License Deal Brings $450M Upfront Cash to Rhythm Pharma
Dine Brands Board Rejects $39/Share Take-Private Bid; Cobblers Cove and Arkhouse Push Back
Mercer Files Prepackaged Chapter 11 Recapitalization: $1.275B Notes Swapped, $400M New Money
Fusemachines Q3 10-Q: Cash Falls to $1.45M, Going Concern Doubt Reaffirmed
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Rollins Family Entity LOR Inc Buys $50M of Stock in Open Market
ARCH Venture Entities and Paul Berns Buy $18M of ASPE at $15.00 IPO Price
Director and 10% Owner Buys $6.0M of Bambusa Stock at $16.00 IPO Price
Hartree Partners Buys 300,000 HDSN Shares for $1.31M Near 52-Week Low
Saba Capital Buys 39,044 MXF Shares for $787K, Lifting Stake to 2.46M
CEO Arik Kaufman Buys 96,826 ADSs for $38,167 in Open Market
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Children's Place Preparing Bankruptcy Filing as Early as Next Week
Karyopharm Files Chapter 11, Strikes Ayrmid Merger With $55M DIP; Equity Wiped Out
Marvell to Acquire Lumentum in $115B All-Stock Deal at 4.500 Exchange Ratio
Marvell Files $115B Lumentum Merger Agreement: 4.5:1 All-Stock, $5.8B Break Fee
Marvell to Acquire Lumentum in $115B All-Stock Deal, 4.5:1 Exchange Ratio
Marvell and Lumentum Agree to Combine in AI Connectivity Deal
$855M LG Chem License Deal Brings $450M Upfront Cash to Rhythm Pharma
Mercer Files Prepackaged Chapter 11 Recapitalization: $1.275B Notes Swapped, $400M New Money
Mercer Strikes Prepackaged Chapter 11 Deal to Cut $1.1B of Senior Notes, Raise $400M
Ribbon Acquisition Gets Nasdaq MVLS Deficiency Notice, 180 Days to Regain $35M Compliance
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.